SAM
AVBP icon

Sectoral Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Sectoral Asset Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Buy
79,043
+49,030
+163% +$1.45M 1.92% 16
2026
Q1 		$720K Sell
30,013
-8,242
-22% -$186K 0.6% 44
2025
Q4 		$770K Sell
38,255
-980
-2% -$20.4K 0.62% 44
2025
Q3 		$724K Buy
39,235
+3,655
+10% +$71.8K 0.45% 59
2025
Q2 		$775K Buy
35,580
+25,490
+253% +$529K 0.51% 51
2025
Q1 		$187K Buy
+10,090
New +$247K 0.15% 73

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sectoral Asset Management's AVBP Position: Q2 2026 in Review

Sectoral Asset Management increased its ArriVent BioPharma (AVBP) stake by 163% in Q2 2026, buying an estimated $1.45M and bringing the position to 79,043 shares worth $2.75M. The position accounts for 1.92% of the portfolio, ranked #16.

Sectoral Asset Management first reported a position in AVBP in Q1 2025 and has held it in 6 quarters since. 158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Sectoral Asset Management held 79,043 shares of ArriVent BioPharma worth $2.75M as of Q2 2026.
  • Sectoral Asset Management bought 49,030 ArriVent BioPharma shares in Q2 2026, an estimated $1.45M.
  • ArriVent BioPharma made up 1.92% of Sectoral Asset Management's portfolio in Q2 2026, its #16 holding.
  • Sectoral Asset Management first reported a position in ArriVent BioPharma in Q1 2025 and has held it in 6 quarters since.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.